Cargando…
Ramelteon, as a Melatonin Agonist, is Expected to be Effective on COVID-19 Induced Organ Damage: The Hypothetic Role of NF-κB Signaling Pathway
Autores principales: | Mehdipoor, Mahdis, Mirmotahari, Seyedeh Azin, Nouriyani, Shima, Salehirad, Mahsa, Darbeheshti, Sepideh, Motaghinejad, Majid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843598/ https://www.ncbi.nlm.nih.gov/pubmed/36660753 http://dx.doi.org/10.4103/abr.abr_60_21 |
Ejemplares similares
-
Survival of COVID-19 patients requires precise immune regulation: The hypothetical immunoprotective role of nicotinic agonists
por: Allahverdi Khani, M., et al.
Publicado: (2020) -
Preventive Properties of Ramelteon against Cocaine-Induced Autophagia and Apoptosis: A Hypothetic Role of TNF-α Receptor Involvement and JNK/Bcl-2-Beclin1 or Bcl-2/Bax Signaling Pathway
por: Kandezi, Niyoosha, et al.
Publicado: (2020) -
Melatonin and Its Agonist Ramelteon in Alzheimer's Disease: Possible Therapeutic Value
por: Srinivasan, Venkatramanujam, et al.
Publicado: (2010) -
Attenuation of Morphine Physical Dependence and Blood Levels of Cortisol by Central and Systemic Administration of Ramelteon in Rat
por: Motaghinejad, Majid, et al.
Publicado: (2015) -
The Melatonin Receptor Agonist Ramelteon Effectively Treats Insomnia and Behavioral Symptoms in Autistic Disorder
por: Kawabe, Kentaro, et al.
Publicado: (2014)